Baxter International (BAX) Cash & Current Investments (2009 - 2026)
Baxter International's (BAX) quarterly Cash & Current Investments came in at $2.0 billion in Q1 2026, down 12.07% year-on-year from $2.3 billion in Q1 2025, and up 2.39% on a QoQ basis from $2.0 billion in Q4 2025.
Baxter International (BAX) Cash & Current Investments (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Cash & Current Investments data on file, last reported at $2.0 billion in Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 12.07% year-over-year to $2.0 billion in Q1 2026; TTM through Mar 2026 was $2.0 billion, a 12.07% decrease from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 11.68% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $2.0 billion, up from $2.0 billion in the prior quarter.
- Over the last five years, Cash & Current Investments for BAX reached as high as $5.7 billion in Q3 2023 and fell as low as $1.4 billion in Q3 2024.
- Historically, Cash & Current Investments has averaged $2.2 billion across 5 years, with a median of $1.8 billion in 2024.
- Across the five-year window, Cash & Current Investments soared 257.03% in 2023 and sank 75.16% in 2024, its largest moves.
- Year by year, Cash & Current Investments stood at $1.6 billion in 2022, then jumped by 89.88% to $3.1 billion in 2023, then tumbled by 42.69% to $1.8 billion in 2024, then rose by 11.68% to $2.0 billion in 2025, then grew by 2.39% to $2.0 billion in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $2.0 billion in Q1 2026, $2.0 billion in Q4 2025, and $1.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.84 Bn | 121.63 Bn | 1.96 Bn | 5.22 Bn |
| 2 | Becton Dickinson | 44.96 Bn | 44.15 Bn | 2.15 Bn | 816.00 Mn |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn | 1.66 Bn |
| 4 | Medline | 32.82 Bn | 30.58 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 23.41 Bn | 22.97 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Solventum | 14.09 Bn | 13.53 Bn | 1.10 Bn | 561.00 Mn |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | 138.80 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Baxter International | 11.93 Bn | 9.92 Bn | 891.00 Mn | 2.02 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.02 Bn |
| Dec 31, 2025 | 1.97 Bn |
| Sep 30, 2025 | 1.73 Bn |
| Jun 30, 2025 | 1.69 Bn |
| Mar 31, 2025 | 2.29 Bn |
| Dec 31, 2024 | 1.76 Bn |
| Sep 30, 2024 | 1.42 Bn |
| Jun 30, 2024 | 1.57 Bn |
| Mar 31, 2024 | 2.83 Bn |
| Dec 31, 2023 | 3.08 Bn |
| Sep 30, 2023 | 5.72 Bn |
| Jun 30, 2023 | 1.72 Bn |
| Mar 31, 2023 | 1.67 Bn |
| Dec 31, 2022 | 1.62 Bn |
| Sep 30, 2022 | 1.60 Bn |
| Jun 30, 2022 | 1.85 Bn |
| Mar 31, 2022 | 2.29 Bn |
| Dec 31, 2021 | 2.95 Bn |
| Sep 30, 2021 | 3.26 Bn |
| Jun 30, 2021 | 3.14 Bn |